Michael Boyle, MD, president and CEO of the Cystic Fibrosis (CF) Foundation, explains how interest in gene therapy and genome editing is growing, as the Foundation strives to leave no CF patient behind in its search for a cure . . .
Home Genome Editing Gene Therapy Laying the Foundation for CF Therapy: An Interview with Michael Boyle
Laying the Foundation for CF Therapy: An Interview with Michael Boyle
[Getty Images/Hemera]